Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors [Phase 1]
Phase 1 study of ELI-002 in KRAS-mutated pancreatic ductal adenocarcinoma and other KRAS-driven solid tumors has completed enrollment, with …
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver [Phase 2]
Phase 2 clinical trial results update evaluating pevonedistat in combination with chemotherapy for biliary tract cancers (cholangiocarcinoma…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors [NA]
This completed clinical trial assessed the feasibility of LCD-SLA 3D printing to assist in overall surgical planning for liver malignant tum…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Study of Pembrolizumab and Olaparib in Bile Duct Cancer [Phase 2]
Phase 2 trial of pembrolizumab plus olaparib in cholangiocarcinoma has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma
A completed clinical trial report examining long-term morbidity after surgery for perihilar cholangiocarcinoma, focusing on postoperative co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms [NA]
This entry notes the completion of a clinical trial evaluating a comprehensive electronic cancer support system for managing cancer-related …
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Photodynamic Therapy for Cholangiocarcinoma [NA]
A completed clinical trial evaluating photodynamic therapy for non-resectable cholangiocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP [NA]
A completed clinical trial evaluated the LMA Gastro dual-channel supraglottic airway device for oxygenation during ERCP procedures.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of Durvalumab plus Tremelimumab with platinum-based chemotherapy for intra…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment [Phase 2, Phase 3]
This document describes a Phase 2/Phase 3 clinical trial evaluating a combination of anlotinib with nab-paclitaxel and S-1 for second-line t…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor [Phase 1]
Phase 1 trial of AB-218, an IDH1 inhibitor, in advanced IDH1-mutant cholangiocarcinoma and other IDH1-mutant solid tumors has been terminate…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
A completed clinical trial from Seoul National University Hospital analyzes outcomes and prognostic factors for hepatopancreatoduodenectomy …
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]
Phase 1/2 trial of BNT141 in CLDN18.2-positive gastric, pancreatic, ovarian, and biliary tract cancers. The study was terminated and results…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients [NA]
A completed clinical trial from Yonsei University evaluated whether oral protein supplements improve nutrition and quality of life after pan…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers [Phase 2]
Phase 2 study of Zanidatamab (ZW25) in advanced or metastatic HER2-amplified biliary tract cancers completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating pemigatinib with durvalumab for previously treated biliary tract carcinoma is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma [Phase 2]
Phase 2 study evaluating tinengotinib (TT-00420) for cholangiocarcinoma has completed; no efficacy or safety results are provided in the sou…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 [Phase 2]
Phase 2 FLUOPANC trial evaluating fluorescence-guided surgery for pancreatic adenocarcinoma and cholangiocarcinoma using the fluorescent age…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations [Phase 3]
Phase 3 trial of BGJ398 (infigratinib) in first-line cholangiocarcinoma with FGFR2 fusions has been terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma [Phase 1]
Phase 1 trial evaluating gemcitabine and cisplatin with either ivosidenib or pemigatinib for unresectable or metastatic cholangiocarcinoma; …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy [Phase 2]
Phase 2 trial update for RRx-001 in second-line treatment of advanced cholangiocarcinoma; study terminated with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma [Phase 2]
Phase 2 clinical trial evaluating trifluridine/tipiracil in combination with irinotecan as second-line therapy for cholangiocarcinoma has co…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: A Study of TAS-120 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of futibatinib (TAS-120) in patients with advanced solid tumors, including cholangiocarcinoma, urothelial carcinoma, breas…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Multiorgan Metabolic Imaging Response Assessment of Abemaciclib [Phase 2]
Phase 2 trial update evaluating multiorgan metabolic imaging response assessment of abemaciclib.